In this study, we found that CML CD34+ cells expressed lower level of Spred2 compared with normal hematopoietic progenitor cells, and adenovirus mediated restoration of Spred2 promoted the erythroid differentiation of CML cells. The gene discussed is SPRED2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.